Treanda Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin Lymphoma
Conditions:   Recurrent Classic Hodgkin Lymphoma;   Refractory Classic Hodgkin Lymphoma Interventions:   Procedure: Autologous Hematopoietic Stem Cell Transplantation;   Drug: Bendamustine;   Drug: Brentuximab Vedotin;   Drug: Carboplatin;   Procedure: Computed Tomography;   Drug: Etoposide;   Drug: Gemcitabine;   Drug: Ifosfamide;   Drug: Pegylated Liposomal Doxorubicin Hydrochlor ide;   Biological: Pembrolizumab;   Procedure: Positron Emission Tomography;   Radiation: Radiation Therapy;   Other: Transplant Conditioning;   Drug: Vinorelbine Sponsor:   National Cancer Institute (...
Source: ClinicalTrials.gov - February 3, 2023 Category: Research Source Type: clinical trials